Luminescent characterization of interaction efficiency between (−)-Cytisine (cas 15191-27-2) and amino acids an indicator of anti-inflammatory of some 12-N-substituted (−)-Cytisine (cas 15191-27-2) derivatives

Add time:08/01/2019    Source:sciencedirect.com

In the present work, the spectral fluorescent properties of N-R-12-N-methylcytisine-3-amines (R = 2-furylmethyl, 2-hydroxybenzyl, 2-thienylmethyl and 2-phenylprop-2-en-1-yl) have been studied and their relative quantum yields and lifetimes in the electronically excited states have been defined. These compounds have bioactivity as potential inhibitors of cyclooxygenase-2 (COX-2). We have studied the quenching of fluorescence (FL) of L-tyrosine (Tyr) and L-tryptophan (Trp) by amino-derivatives of 12-N-methylcytisine as well as the FL quenching of cytisines themselves by L-serine (Ser) and L-arginine (Arg). The found Stern–Volmer constants and lifetimes of the excited states reveal static mechanism of the quenching of aromatic amino acids and dynamic mechanism for the FL quenching of cytisines by Arg (Ser does not quench FL) due to the reversible photo-induced electron transfer (PET). The thermodynamic assessment of the PET probability according to the Weller equation agrees with the observed regularities and series of bioactivity of the cytisines. Using molecular docking, we have found the most probable positions of the 12-N-methylcytisine derivatives in the active site of COX-2 where their stacking interactions with Trp387 and Tyr385 and hydrogen bonding with Arg120 and Ser530 occur. As the mentioned amino acids play a key role in the complexion of the studied compounds by COX-2, we have proposed that bioactivity mechanism of the lead compounds implies the COX-2 inhibition by the withdrawal of electron from electron-transfer processes in the chain HEM–His388–Trp387–His386–Tyr385 resulted from their stacking interactions with Trp and/or Tyr.

We also recommend Trading Suppliers and Manufacturers of Cytisine (cas 15191-27-2). Pls Click Website Link as below: cas 15191-27-2 suppliers

Prev:Agonist and antagonist effects of Cytisine (cas 15191-27-2) in vivo
Next:Designing and preparation of Cytisine (cas 15191-27-2) alkaloid surface-imprinted material and its molecular recognition characteristics)